KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Finished Goods: 2018-2025

Historic Finished Goods for Twist Bioscience (TWST) over the last 5 years, with Sep 2025 value amounting to $5.9 million.

  • Twist Bioscience's Finished Goods rose 26.80% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 26.80%. This contributed to the annual value of $5.9 million for FY2025, which is 26.80% up from last year.
  • Per Twist Bioscience's latest filing, its Finished Goods stood at $5.9 million for Q3 2025, which was down 9.69% from $6.5 million recorded in Q2 2025.
  • Twist Bioscience's Finished Goods' 5-year high stood at $9.6 million during Q1 2022, with a 5-year trough of $1.9 million in Q1 2021.
  • Over the past 3 years, Twist Bioscience's median Finished Goods value was $4.8 million (recorded in 2024), while the average stood at $5.1 million.
  • Per our database at Business Quant, Twist Bioscience's Finished Goods skyrocketed by 693.89% in 2021 and then slumped by 48.71% in 2023.
  • Quarterly analysis of 5 years shows Twist Bioscience's Finished Goods stood at $6.8 million in 2021, then rose by 9.90% to $7.4 million in 2022, then crashed by 36.47% to $4.7 million in 2023, then climbed by 2.75% to $4.8 million in 2024, then increased by 26.80% to $5.9 million in 2025.
  • Its Finished Goods was $5.9 million in Q3 2025, compared to $6.5 million in Q2 2025 and $5.0 million in Q1 2025.